12:00 AM
 | 
Oct 19, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

MDRNA preclinical data

In rodent models of bladder cancer, intravesical UsiRNA against survivin showed >90% dose-dependent survivin mRNA inhibition...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >